Andrew DeCastro

713 total citations
15 papers, 472 citations indexed

About

Andrew DeCastro is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Andrew DeCastro has authored 15 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Andrew DeCastro's work include Multiple Myeloma Research and Treatments (3 papers), Protein Degradation and Inhibitors (3 papers) and Cancer-related Molecular Pathways (3 papers). Andrew DeCastro is often cited by papers focused on Multiple Myeloma Research and Treatments (3 papers), Protein Degradation and Inhibitors (3 papers) and Cancer-related Molecular Pathways (3 papers). Andrew DeCastro collaborates with scholars based in United States, United Kingdom and Spain. Andrew DeCastro's co-authors include Nanjoo Suh, Amanda K. Smolarek, James DiRenzo, Pratima Cherukuri, Hong Jin Lee, Shiby Paul, Jae Young So, Barbara Simi, Agnes M. Rimando and Renping Zhou and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Andrew DeCastro

15 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew DeCastro United States 11 249 156 97 71 56 15 472
Gauri Deb United States 10 357 1.4× 80 0.5× 98 1.0× 52 0.7× 34 0.6× 18 542
Serina King United States 8 342 1.4× 129 0.8× 77 0.8× 33 0.5× 26 0.5× 18 527
Youqiu Xue China 13 331 1.3× 173 1.1× 57 0.6× 20 0.3× 34 0.6× 18 734
Ana Nedeljkovic-Kurepa United States 7 249 1.0× 107 0.7× 67 0.7× 42 0.6× 96 1.7× 11 464
Valentina Della Pietra Italy 11 433 1.7× 183 1.2× 75 0.8× 64 0.9× 51 0.9× 13 777
Xiang-Lin Tan United States 11 267 1.1× 165 1.1× 117 1.2× 18 0.3× 40 0.7× 13 440
Nader S. Shenouda United States 5 210 0.8× 84 0.5× 57 0.6× 50 0.7× 97 1.7× 5 391
Itishree Kaushik United States 10 435 1.7× 212 1.4× 156 1.6× 41 0.6× 30 0.5× 12 756
Amit Kumar Verma India 15 307 1.2× 104 0.7× 133 1.4× 49 0.7× 34 0.6× 41 639
Mary S. Sakla United States 5 234 0.9× 78 0.5× 43 0.4× 52 0.7× 72 1.3× 5 399

Countries citing papers authored by Andrew DeCastro

Since Specialization
Citations

This map shows the geographic impact of Andrew DeCastro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew DeCastro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew DeCastro more than expected).

Fields of papers citing papers by Andrew DeCastro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew DeCastro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew DeCastro. The network helps show where Andrew DeCastro may publish in the future.

Co-authorship network of co-authors of Andrew DeCastro

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew DeCastro. A scholar is included among the top collaborators of Andrew DeCastro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew DeCastro. Andrew DeCastro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Leleu, Xavier, María‐Victoria Mateos, Sundar Jagannath, et al.. (2021). Effects of refractory status to lenalidomide on safety and efficacy of selinexor, bortezomib, and dexamethasone (XVd) versus bortezomib and dexamethasone (Vd) in patients with previously treated multiple myeloma.. Journal of Clinical Oncology. 39(15_suppl). 8024–8024. 4 indexed citations
2.
Chari, Ajai, Dan T. Vogl, Sundar Jagannath, et al.. (2020). Selinexor‐based regimens for the treatment of myeloma refractory to chimeric antigen receptor T cell therapy. British Journal of Haematology. 189(4). e126–e130. 12 indexed citations
3.
Mouhieddine, Tarek H., Samir Parekh, Hearn Jay Cho, et al.. (2020). MM-103: Selinexor, Bortezomib, and Dexamethasone (SVD) in Heavily Treated Relapsed Refractory Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 20. S292–S293. 1 indexed citations
4.
Chari, Ajai, Dan T. Vogl, Sundar Jagannath, et al.. (2019). Selinexor-Containing Regimens for the Treatment of Patients with Multiple Myeloma Refractory to Chimeric Antigen Receptor T-Cell (CAR-T) Therapy. Blood. 134(Supplement_1). 1854–1854. 6 indexed citations
5.
Cherukuri, Pratima, et al.. (2015). p53 and ΔNp63α Coregulate the Transcriptional and Cellular Response to TGFβ and BMP Signals. Molecular Cancer Research. 13(4). 732–742. 18 indexed citations
6.
DeCastro, Andrew, et al.. (2014). ΔNP63α Transcriptionally Activates Chemokine Receptor 4 (CXCR4) Expression to Regulate Breast Cancer Stem Cell Activity and Chemotaxis. Molecular Cancer Therapeutics. 14(1). 225–235. 14 indexed citations
7.
DeCastro, Andrew & James DiRenzo. (2014). miRNA function and modulation in stem cells and cancer stem cells. SHILAP Revista de lepidopterología. 1(1). 1 indexed citations
8.
9.
Cherukuri, Pratima, et al.. (2012). Phosphorylation of ΔNp63α via a Novel TGFβ/ALK5 Signaling Mechanism Mediates the Anti-Clonogenic Effects of TGFβ. PLoS ONE. 7(11). e50066–e50066. 11 indexed citations
10.
DeCastro, Andrew, Pratima Cherukuri, Karen T. Liby, et al.. (2012). ΔNp63α-Mediated Activation of Bone Morphogenetic Protein Signaling Governs Stem Cell Activity and Plasticity in Normal and Malignant Mammary Epithelial Cells. Cancer Research. 73(2). 1020–1030. 51 indexed citations
11.
DeCastro, Andrew, et al.. (2011). ΔNp63α promotes cellular quiescence via induction and activation of Notch3. Cell Cycle. 10(18). 3111–3118. 18 indexed citations
12.
Suh, Nanjoo, Bandaru S. Reddy, Andrew DeCastro, et al.. (2011). Combination of Atorvastatin with Sulindac or Naproxen Profoundly Inhibits Colonic Adenocarcinomas by Suppressing the p65/β-Catenin/Cyclin D1 Signaling Pathway in Rats. Cancer Prevention Research. 4(11). 1895–1902. 57 indexed citations
13.
DeCastro, Andrew, Amanda K. Smolarek, Jae Young So, et al.. (2010). Dietary intake of pterostilbene, a constituent of blueberries, inhibits the  -catenin/p65 downstream signaling pathway and colon carcinogenesis in rats. Carcinogenesis. 31(7). 1272–1278. 114 indexed citations
14.
Lee, Hong Jin, Andrew DeCastro, Amanda K. Smolarek, et al.. (2010). Gemini vitamin D analog suppresses ErbB2-positive mammary tumor growth via inhibition of ErbB2/AKT/ERK signaling. The Journal of Steroid Biochemistry and Molecular Biology. 121(1-2). 408–412. 28 indexed citations
15.
Lee, Hong Jin, Jihyeung Ju, Shiby Paul, et al.. (2009). Mixed Tocopherols Prevent Mammary Tumorigenesis by Inhibiting Estrogen Action and Activating PPAR-γ. Clinical Cancer Research. 15(12). 4242–4249. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gauri Deb Breakdown of academic impact, for papers by Serina King Breakdown of academic impact, for papers by Youqiu Xue Breakdown of academic impact, for papers by Ana Nedeljkovic-Kurepa Breakdown of academic impact, for papers by Valentina Della Pietra Breakdown of academic impact, for papers by Xiang-Lin Tan Breakdown of academic impact, for papers by Nader S. Shenouda Breakdown of academic impact, for papers by Itishree Kaushik Breakdown of academic impact, for papers by Amit Kumar Verma Breakdown of academic impact, for papers by Mary S. Sakla
Rankless by CCL
2026